NCT04877431View on ClinicalTrials.gov

A Study of Teduglutide (Revestive®) in Children, Teenagers and Adults With Short Bowel Disease

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

November 5, 2020

Primary Completion Date

June 5, 2023

Study Completion Date

June 5, 2023

Conditions
Short Bowel Syndrome
Trial Locations (1)

C1055AAD

IC Projects, Buenos Aires

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY